Unicycive Therapeutics, Inc. - Common Stock (UNCY)
4.9000
+0.1300 (2.73%)
NASDAQ · Last Trade: Jul 1st, 4:55 PM EDT
Detailed Quote
Previous Close | 4.770 |
---|---|
Open | 5.000 |
Bid | 4.900 |
Ask | 4.930 |
Day's Range | 4.800 - 5.040 |
52 Week Range | 2.020 - 11.00 |
Volume | 1,393,758 |
Market Cap | 71.09M |
PE Ratio (TTM) | -9.608 |
EPS (TTM) | -0.5 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,419,160 |
Chart
About Unicycive Therapeutics, Inc. - Common Stock (UNCY)
Unicycive Therapeutics Inc is a biotechnology company focused on developing innovative therapies to address unmet medical needs, particularly in the areas of kidney diseases. The company is primarily engaged in creating novel drug candidates that enhance the management of renal conditions, aiming to improve patient outcomes through targeted treatments. By leveraging its expertise in drug development and its commitment to scientific research, Unicycive Therapeutics seeks to bring forth new solutions that can significantly impact the lives of individuals suffering from various kidney-related disorders. Read More
News & Press Releases
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 30, 2025
NEW YORK, NY - June 30, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).
Via TheNewswire.com · June 30, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · June 30, 2025
FDA denies Unicycive's NDA for Oxylanthanum Carbonate due to vendor issues; company eyes quick resolution with alternate manufacturer in place.
Via Benzinga · June 30, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · June 30, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 30, 2025
Via Benzinga · June 30, 2025
Via Benzinga · June 25, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · June 17, 2025
Via Benzinga · June 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 13, 2025
NEW YORK, NY - June 13, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).
Via TheNewswire.com · June 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 11, 2025
NEW YORK, NY - June 11, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).
Via TheNewswire.com · June 11, 2025
NEW YORK, NY - June 10, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).
Via TheNewswire.com · June 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 10, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · June 10, 2025
Unicycive announced update on its NDA for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis.
Via Benzinga · June 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 10, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · June 10, 2025
Via Benzinga · June 10, 2025

Via Benzinga · June 2, 2025

Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · June 2, 2025